Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 87 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
861 13.0 months Non-squamous NSCLC 5 Biologic therapy
Chemotherapy
San Luigi Hospital Italy 8/2012
Treatment Details: Patients: This study involved non-squamous non-small-cell lung cancer patients, not previously treated with chemotherapy, who were separated into two different treatment groups. Group A ha
 
862 13.0 months Castration-resistant prostate cancer 5 Biologic therapy
Advocate Lutheran General Hospital United States 10/2013
Treatment Details: Patients: This phase 2 study involved 21 castration-resistant prostate cancer patients who had not received prior chemotherapy. The median patient age was 74 years. Treatment: Patients
 
863 13.0 months Advanced triple-negative breast cancer 5 Chemotherapy
Université Libre de Bruxelles Belgium 4/2014
Treatment Details: Patients: This phase 2 study involved female advanced triple-negative breast cancer (TNBC) patients who were divided into three separate treatment groups. Group A consisted of 55 patients
 
864 12.9 months Metastatic melanoma 4 Biologic therapy
Istituto Nazionale Tumori Fondazione Pascale Italy 9/2013
Treatment Details: Patients: This phase 2 study involved metastatic melanoma patients who were divided into separate groups based on the specific genetic mutation of their cancer. Group A consisted of 76 pat
 
865 12.9 months progressive or recurrent ovarian cancer 4 Chemotherapy
Catholic University, Campobasso Italy 2/2008
Treatment Details: Patients: This phase III trial involved 153 women with recurrent or progressive ovarian cancer. The median age was 63 years old, ranging from 28 to 80. Treatment: The women were treate
 
866 12.9 months Metastatic colorectal 5 Biologic therapy
Chemotherapy
Fox Chase Cancer Center United States 4/2007
Treatment Details: Patients: This phase III study involved 829 patients with metastatic colorectal cancer. They had previously been treated with fluoropyrimidine and irinotecan. They ranged in age from 21 to
 
867 12.9 months Advanced NSCLC 5 Chemotherapy
Chang Gung Memorial Hospital, Taipei, Chang Gung University College of Medicine, Taoyuan Taiwan Region 12/2008
Treatment Details: Patients: This study involved eighty-three patients with advanced non-small cell lung cancer. These patients ranged in age from 23 to 85 years of age. Treatment: Patients were treated
 
868 12.8 months Metastatic colorectal cancer 5 Chemotherapy
Centro de Oncologia do Hospital Sirio Libanes Brazil 8/2008
Treatment Details: Patients: This phase II study involved 98 patients with metastatic colorectal cancer. There were 58 men and 40 women. The median age was 64, ranging from 38 to 93 years of age. Treat
 
869 12.8 months Metastatic breast cancer 4 Biologic therapy
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center United States 6/2008
Treatment Details: Patients: This phase II study involved 14 women with treatment-refractory metastatic breast cancer. The median age was 58, ranging from 40-90 years. The majority were Caucasian/white (92.9
 
870 12.8 months Metastatic colorectal cancer 3 Chemotherapy
The University of Texas M.D. Anderson Cancer Center United States 6/2004
Treatment Details: Patients: This Phase II study involved 22 patients with metastatic colorectal cancer. All patients had been previously treated with 5-FU. Treatment: Treatment consisted of the chemother
 
Page 87 of 187  | Previous Page  | Next Page